Ochsner Health pioneers new treatments, deploys emerging technologies and performs groundbreaking research, including 4,000 patients enrolled in 685 clinical studies in 2022
Current AD research focuses on understanding pathology by targeting several mechanisms, such as abnormal tau protein metabolism, -amyloid, inflammatory response, and cholinergic and free radical damage, aiming to develop successful treatments that are capable of stopping or modifying the course of AD (Breijyeh and Karaman, 2020)
Side effects are generally mild and temporary (nausea, flushing, injection site tenderness)
Impact of GLP-1 receptor agonist use in patients with steatotic liver disease and type 2 diabetes: a retrospective cohort study
Why might you stop taking semaglutide Some reasons you might stop taking semaglutide include: Your tolerance for side effects: Nausea, vomiting, diarrhea, constipation, and stomach pain are common side effects of semaglutide , especially in the first 812 weeks